These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A soluble interaction between dibutyryl cyclic guanosine 3':5'-monophosphate and cholecystokinin: a possible mechanism for the inhibition of cholecystokinin activity. Miller LJ, Reilly WM, Rosenzweig SA, Jamieson JD, Go VL. Gastroenterology; 1983 Jun; 84(6):1505-11. PubMed ID: 6301926 [Abstract] [Full Text] [Related]
27. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP. Collins SM, Abdelmoumene S, Jensen RT, Gardner JD. Am J Physiol; 1981 Jun; 240(6):G466-71. PubMed ID: 6166201 [Abstract] [Full Text] [Related]
29. The mechanisms by which dibutyryl cyclic GMP antagonizes the action of cholecystokinin. Miller LJ, Reilly WM, Rosenzweig SA, Jamieson JD, Go VL. Gastroenterology; 1983 Jun; 84(6):1637-9. PubMed ID: 6301928 [No Abstract] [Full Text] [Related]
30. Mechanism by which dibutyryl cyclic guanosine monophosphate antagonizes the action of cholecystokinin. Gardner JD. Gastroenterology; 1983 Jun; 84(6):1619-21. PubMed ID: 6301927 [No Abstract] [Full Text] [Related]
31. A soluble interaction between dibutyryl cyclic guanosine 3':5'-monophosphate and cholecystokinin: a possible mechanism for the inhibition of cholecystokinin activity. Miller LJ, Reilly WM, Rosenzweig SA, Jamieson JD, Go VL. Gastroenterology; 1983 Jun; 84(6):1505-11. PubMed ID: 6301926 [Abstract] [Full Text] [Related]